Using Nicotine to Reverse Age-related Auditory Processing Deficits
Part of paid clinical trials in Irvine, California.
- Sponsor
- University of California, Irvine
- Study ID
- NCT04971954
- Status
- Recruiting
Conditions
- Aging
- Auditory Perceptual Impairment
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Accepted
Interventions
- Nicotine gum — OTHERNicotine (6 mg) will be administered in the form of polacrilex gum that is available as an over-the-counter medication
- Placebo gum — OTHERThe placebo will also be a commercially available gum that resembles the nicotine gum in flavor, size, shape, color, and texture.
Study Details
The present study will evaluate the effects of both aging and nicotine on psychophysical tasks and electrophysiological measures. Nicotine will be administered to study participants in the form of gum that is available as an over-the-counter medication. The hypothesis is that nicotine will reverse the detrimental effects of aging on auditory processing. The proposed experiments will characterize the effects of nicotine and may eventually lead to improved treatments of hearing loss in a variety of patient populations and in healthy aging.
Key Dates
- Start date
- Feb 1, 2022
- Status verified
- Mar 2026
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 48 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Nicotine gumNicotine (6 mg) will be administered in the form of polacrilex gum that is available as an over-the-counter medication
- Placebo Comparator: Placebo gumThe placebo will also be a commercially available gum that resembles the nicotine gum in flavor, size, shape, color, and texture.
Primary Outcome Measure
Hearing thresholds [ Time Frame: 1 hour ]
Central Contacts
- Fan-Gang Zeng9498249107
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hearing and Speech Lab | Irvine | California | 92697 |
Find similar trials in Irvine, CA
By research site
Related Studies
- Evaluation of the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli OrisPHASE4 · Not Yet Recruiting · Amir Moradi MD, MBA · Vista, California
- Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's DiseaseRecruiting · Neurobehavioral Systems, Inc. · Berkeley, California
- Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized EldersRecruiting · University of Michigan · Orange, California
- Effect of Gerofit Exercise on Cognition in Older VeteransRecruiting · VA Office of Research and Development · West Los Angeles, California